3 ASX lithium shares to buy with 40%+ upside: analysts

These lithium shares could have major upside potential…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Lithium shares have fallen heavily in recent months
  • Brokers appears to see this as a buying opportunity for investors
  • Three lithium shares have been tipped to generate huge returns in 2023

While recent weakness in the lithium industry has been disappointing, it could prove to be a great buying opportunity for investors.

That appears to be the view of a number of analysts that have buy ratings and lofty price targets on these ASX lithium shares.

Here's what you need to know:

A man wearing a suit holds his arms aloft, attached to a large lithium battery with green charging symbols on it.

Image source: Getty Images

Allkem Ltd (ASX: AKE)

Goldman Sachs is very positive on this speciality lithium chemicals company despite expecting lithium prices to fall materially in the coming years. This is due to Allkem's plan to grow its production 4x in the medium term in a manner that allows it to command a 10% share of global lithium demand. The broker expects this production growth to offset weaker lithium prices and support its earnings. In addition, it sees opportunities for the company to benefit from value-added downstream activities.

Goldman Sachs currently has a buy rating and $15.20 price target on its shares. Based on the latest Allkem share price, this suggests potential upside of 38%.

Liontown Resources Limited (ASX: LTR)

Liontown Resources is the name behind the 100%-owned Kathleen Valley and Buldania projects in Western Australia. Bell Potter is a fan of this lithium developer. The broker highlights that the company has the backing of major downstream EV participants such as Tesla and Ford. It also notes that the Kathleen Valley lithium project's scale and mine life lend optionality to future product value-adding through downstream lithium refining.

Bell Potter has a speculative buy rating and $2.87 price target on Liontown's shares. This implies potential upside of 130% for investors.

Pilbara Minerals Ltd (ASX: PLS)

Macquarie is bullish on this lithium giant, which owns the enormous Pilgangoora Project. It is one of the largest hard rock lithium deposits in the world and considered strategically important within the global lithium supply chain. Macquarie believe Pilbara Minerals is well-placed to deliver bumper free cash flow in 2023. So much so, it is expecting a dividend yield of almost 9% next year.

Macquarie has an outperform rating and $7.50 price target on its shares. This is more than double the current Pilbara Minerals share price of $3.67.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »